Abstract
Recent studies indicate that taurine levels are reduced both in plasma3 and platelets obtained from patients with insulin-dependent diabetes mellitus (IDDM) in the absence of any complications of disease3. We have demonstrated that between plasma taurine levels and glycosylated hemoglobin levels (HbAlc) there is an inverse linear correlation indicating that taurine levels could be of some relevance in the control of metabolic state3. Moreover, when taurine levels are increased by taurine supplementation, the sensitivity of platelets obtained from IDDM patients to arachidonic acid is decreased3.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Born, G. V. R., and Cross, M. J., 1963, The aggregation of blood platelets, J. Physiol. 168, 178.
Davi, G., Catalano, I., Arena, A., Notarbartolo, A., Strano, A., Ciabattoni, G., and Patrono, C., 1990, Thromboxane biosynthesis and platelet in type 2 diabetes mellitus, N. Eng. J. Med. 322, 1769.
Franconi, F., Bennardini, F., Mattana, A., Miceli, M., Ciuti, M., Mian, M., Gironi, A., Bartolomei, G. C., Anichini, R., and Seghieri, G., 1995, Taurine deficiency in insulin-dependent diabetes mellitus (IDDM): Effect of taurine supplementation, Am. J. Clin. Nutr. 61, 1115.
Geggel, H. S., Ament, M. E., Heckenlively, J. R., Martin, D. A., and Kapple, J. D., 1985, Nutritional requirement for taurine in patients receiving long-term parenteral nutrition, N. Eng. J. Med. 312, 142.
Halushka, P. U., Rogers, R. C., Loadholt, C. B., and Colwell, J. A., 1981, Increased platelet thromboxane synthesis in diabetes mellitus, J. Lab. Clin. Med. 97, 87.
Hayes, K. C., Carey, R. E., and Schmidt, S. Y., 1975, Retinal degeneration associated with taurine deficiency in the cat, Science 188, 949.
Hayes, K. C., Pronezn, K. A., Addessa, A. E., and Stephan, Z. F., 1989, Taurine modulates platelet aggregation in cats and humans, Am. J. Clin. Nutr. 49, 1211.
Jones, B. N., and Gilligan, J. P., 1983, O-phtalaldehyde pre-column derivatization and reversed-phase high performance liquid chromatography of polypeptide hydrolisates and physiological fluid, J. Chromatogr. 226, 471.
Kaneti-Kaa, A., Goldberg, R. E., and Walsh, P. N., 1984, Platelet coagulant activities in diabetes mellitus: Evidences for platelet coagulant hyperactivity and platelet volume, J. Lab. Clin. Med. 103, 82.
Miceli, M., Bennardini, F., Mattana, A., Cavarrubias, J., Saghieri, G., Franconi, F., 1992, Taurine modifies platelet sensitivity to aspirin, indomethacin, sodium nitroprusside and papaverine, Platelets 3, 265.
Mustard, J. F., and Packman, M. A., 1984, Platelets and diabetes mellitus, N. Eng. J. Med. 311, 665.
National Diabetes Data Group, 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intollerance, Diabetes 28, 1039.
Sturman, J. A., Wen, G. Y., Wisniewski, H. M., and Neuringer, M. D., 1984, Retinal degeneration in primates raised on a synthetic human infant formula, Int. Dev Neurosci. 2, 121.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Franconi, F. et al. (1996). Taurine and Diabetes. In: Huxtable, R.J., Azuma, J., Kuriyama, K., Nakagawa, M., Baba, A. (eds) Taurine 2. Advances in Experimental Medicine and Biology, vol 403. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0182-8_62
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0182-8_62
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0184-2
Online ISBN: 978-1-4899-0182-8
eBook Packages: Springer Book Archive